A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Durability of DLQI Improvements Among Patients with Moderate to Severe Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2)
2020
SKIN The Journal of Cutaneous Medicine
not available.
doi:10.25251/skin.4.supp.80
fatcat:ducnvjlzmngrzfwnytutmeidle